Local Institution - 0133

Krakow 31-115

0 studies enrolling now · 1 studies all time

What they study most

Unresectable or Metastatic Melanoma

Studies at this site

• Phase 3 Study of Nivolumab or Nivolumab Plus Ipilimumab Versus Ipilimumab Alone in Previously Untreated Advanced Melanoma (CheckMate 067) — Completed